Latest Ranbaxy Laboratories Stories

2008-07-19 09:00:17

By Alistair Dawber The increase in merger deals involving generic drug companies has continued apace after Israel's Teva Pharmaceuticals announced it was buying its American rival Barr, the fourth-biggest group in the sector, for $7.5bn (3.75bn).

2008-06-19 09:00:42

DALLAS | Airlines executives are continuing to cut jobs and consider new fees on passengers as they battle high fuel prices. Executives from United Airlines gave more details on plans to shed up to 1,600 salaried jobs at an investors' conference in New York on Wednesday.

2008-02-13 11:00:00

Patches sold in the United States under the brand name Duragesic which contain the painkiller fentanyl were recalled on Tuesday.

2007-10-29 12:00:47

India's Ranbaxy Laboratories has received tentative approval from the FDA to market four dosage strenghs of valsartan, a generic version of Novartis's hypertension drug Diovan. Valsartan is indicated for the treatment of hypertension alone or in combination with other anti-hypertensive agents.

2006-07-25 00:57:38

By Irwin Arieff UNITED NATIONS (Reuters) - U.N. Secretary-General Kofi Annan encouraged executives from nine drug companies on Monday to lower prices of AIDS medicines and step up efforts to develop AIDS drugs and diagnostics for children.

2006-03-20 10:35:00

China will leapfrog Britain and Italy to become the world's fifth most valuable pharmaceuticals market by 2010, industry experts said on Monday.

2005-12-01 12:50:00

Indian generic drug company Ranbaxy Laboratories Ltd. said on Thursday that it was prepared to produce large quantities of Tamiflu for the United States to help meet the threat of avian flu and was in talks with the drug's maker, Roche Holding AG.

2005-09-08 14:54:55

WASHINGTON (Reuters) - U.S. health officials on Thursday granted tentative approval for a generic liquid version of the AIDS drug AZT, allowing it to be used overseas under a U.S. program to fight the deadly virus.

2005-08-12 10:07:43

WASHINGTON (Reuters) - Patients and doctors must register with manufacturers before using or prescribing Roche Holding AG's acne drug Accutane or its generic versions, U.S. regulators said on Friday.